Literature DB >> 12924649

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.

Deepak V Gopal1, David A Lieberman, Nathan Magaret, M Brian Fennerty, Richard E Sampliner, Harinder S Garewal, Gary W Falk, Douglas O Faigel.   

Abstract

Studies show Barrett's esophagus prevalence increases with age, while mean length of Barrett's esophagus is unchanged. Few data are available about the relationship between age and length on the development of dysplasia. Our aim was to assess age and length as risk factors for dysplasia. Consecutive patients with Barrett's esophagus were enrolled in a multicenter study establishing a tissue bank of Barrett's esophagus patients 1994 and 1998. Demographics, length of Barrett's esophagus (centimeters), and histology were recorded. Risk factors for dysplasia were assessed, including patient age, gender, and length of Barrett's esophagus. Statistical analysis was performed comparing prevalence of dysplasia (which included the presence of any carcinoma and high- or low-grade dysplasia) to age and length. In all, 309 patients were studied [278 (90%) male and 31 (10%) female]: 5 had adenocarcinoma of the esophagus, 11 had high-grade dysplasia, and 29 had low-grade dysplasia. Patients with Barrett's esophagus without dysplasia were younger than those with dysplasia [62 +/- 0.8 years vs 67 +/- 1.7 years (mean +/- SEM, P = 0.02)]. The risk of dysplasia increased by 3.3%/yr of age. Mean length of Barrett's esophagus in patients with Barrett's alone vs dysplasia was 4.0 +/- 0.2 cm vs 5.4 +/- 0.4 cm (P = 0.003). Patients with Barrett's esophagus length > or = 3 cm had a significantly greater prevalence of dysplasia compared to length < 3 cm (23% vs 9%, P = 0.0001). The risk of dysplasia increased by 14%/cm of increased length. Multivariate analysis showed age and length to be independent risk factors. In conclusions: prevalence of dysplasia is strongly associated with age and length of Barrett's esophagus. These preliminary results can be used to develop a strategy for screening/surveillance based on age and length of Barrett's epithelium.

Entities:  

Mesh:

Year:  2003        PMID: 12924649     DOI: 10.1023/a:1024715824149

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium.

Authors:  A J Cameron; C T Lomboy
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

2.  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.

Authors:  D J Drewitz; R E Sampliner; H S Garewal
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

Review 3.  Biomarkers for malignancy in the columnar-lined esophagus.

Authors:  A K Rustgi
Journal:  Gastroenterol Clin North Am       Date:  1997-09       Impact factor: 3.806

4.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

Authors:  B J Reid; R C Haggitt; C E Rubin; G Roth; C M Surawicz; G Van Belle; K Lewin; W M Weinstein; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1988-02       Impact factor: 3.466

5.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.

Authors:  B J Reid; W M Weinstein; K J Lewin; R C Haggitt; G VanDeventer; L DenBesten; C E Rubin
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

6.  Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Authors:  R E Rudolph; T L Vaughan; B E Storer; R C Haggitt; P S Rabinovitch; D S Levine; B J Reid
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

7.  Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

Authors:  P Sharma; T G Morales; A Bhattacharyya; H S Garewal; R E Sampliner
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

8.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

9.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Authors:  W K Hirota; T M Loughney; D J Lazas; C L Maydonovitch; V Rholl; R K Wong
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Lack of impact of therapy on extent of Barrett's esophagus in 67 patients.

Authors:  R E Sampliner; H S Garewal; M B Fennerty; M Aickin
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

View more
  27 in total

1.  The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.

Authors:  B T Theron; H Padmanabhan; H Aladin; P Smith; E Campbell; P Nightingale; B T Cooper; N J Trudgill
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

Review 2.  Are screening and surveillance for Barrett's oesophagus really worthwhile?

Authors:  P Sharma; E I Sidorenko
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Authors:  Shivaram Bhat; Helen G Coleman; Fouad Yousef; Brian T Johnston; Damian T McManus; Anna T Gavin; Liam J Murray
Journal:  J Natl Cancer Inst       Date:  2011-06-16       Impact factor: 13.506

Review 4.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

Review 5.  Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.

Authors:  Raf Bisschops; Miguel Areia; Emmanuel Coron; Daniela Dobru; Bernd Kaskas; Roman Kuvaev; Oliver Pech; Krish Ragunath; Bas Weusten; Pietro Familiari; Dirk Domagk; Roland Valori; Michal F Kaminski; Cristiano Spada; Michael Bretthauer; Cathy Bennett; Carlo Senore; Mário Dinis-Ribeiro; Matthew D Rutter
Journal:  United European Gastroenterol J       Date:  2016-08-21       Impact factor: 4.623

Review 6.  Natural history of Barrett's esophagus.

Authors:  Rao Milind; Stephen E Attwood
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 7.  Clinical implications of molecular changes in pediatric Barrett's esophagus.

Authors:  Licia Pensabene; Marta C Cohen; Michael Thomson
Journal:  Curr Gastroenterol Rep       Date:  2012-06

8.  Editorial: Best Practices in Surveillance of Barrett's Esophagus.

Authors:  Sachin Wani; Srinivas Gaddam
Journal:  Am J Gastroenterol       Date:  2017-07       Impact factor: 10.864

Review 9.  Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.

Authors:  Francisco Schlottmann; Daniela Molena; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

10.  Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all.

Authors:  Shanmugarajah Rajendra; Kannan Kutty; Norain Karim
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.